Mar 1
|
Myriad Genetics (MYGN) to Evaluate MRD Testing With New Pact
|
Mar 1
|
Quest Diagnostics (DGX) Hurt by Lower Testing Sales, Competition
|
Mar 1
|
Veeva Systems (VEEV) Q4 Earnings Surpass Estimates, Margins Up
|
Mar 1
|
Bruker (BRKR) Inks Definitive Agreement to Acquire ELITechGroup
|
Mar 1
|
Veradigm (MDRX) to Acquire AI Service Provider ScienceIO
|
Mar 1
|
New Strong Buy Stocks for March 1st
|
Mar 1
|
Best Income Stocks to Buy for March 1st
|
Feb 29
|
Inari Medical (NARI) Q4 Earnings Improve Y/Y, Gross Margin Down
|
Feb 29
|
Merit Medical (MMSI) Q4 Earnings Top Estimates, Gross Margin Up
|
Feb 29
|
Integra's (IART) Q4 Earnings Miss Estimates, Margins Down
|
Feb 29
|
DENTSPLY SIRONA (XRAY) Q4 Earnings Beat Estimates, Sales Up Y/Y
|
Feb 29
|
National Vision (EYE) Q4 Earnings Top Estimates, Margins Fall
|
Feb 29
|
Nevro (NVRO) Gets FDA Nod for SI Fixation Without Lateral Screw
|
Feb 29
|
Chemed (CHE) Q4 Earnings Surpass Estimates, Margins Expand
|
Feb 29
|
Cardinal Health annual research report examines milestone year in biosimilars
|
Jan 31
|
Cardinal Health to acquire Specialty Networks and its PPS Analytics platform, a technology enabled multi-specialty group purchasing and practice enhancement organization in urology, rheumatology and gastroenterology
|
Jan 30
|
What's in Store for Cardinal Health (CAH) in Q2 Earnings?
|
Jan 29
|
Ahead of Cardinal (CAH) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics
|
Jan 25
|
Cardinal Health (CAH) Earnings Expected to Grow: Should You Buy?
|
Jan 16
|
Illumina (ILMN) Shares Down 1.2% Post Preliminary Q4 Results
|